Access to Breast Cancer Diagnosis Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Access to Breast Cancer Diagnosis Act of 2023 is a House bill introduced in the 118th Congress aimed at improving access to breast cancer diagnosis. The bill was referred to the Subcommittee on Health but did not advance further and is currently classified as failed or expired. No official summary or full text is available, limiting detailed analysis of its provisions. The bill falls under the health policy area and presumably addresses issues related to breast cancer diagnostic services.
This bill sought to enhance breast cancer diagnostic access but did not progress beyond subcommittee referral and is now expired.
- The bill is titled Access to Breast Cancer Diagnosis Act of 2023 and was introduced in the House of Representatives.
- It was referred to the Subcommittee on Health on December 17, 2024, but no further legislative action occurred.
- No official summary or full text is publicly available, restricting detailed policy analysis.
['Individuals at risk for or suspected of having breast cancer who require diagnostic services', 'Healthcare providers and facilities involved in breast cancer diagnosis', 'Public health agencies focused on cancer detection and treatment']
['Lack of publicly available bill text and summary limits understanding of implementation requirements and funding mechanisms', 'Unclear oversight and enforcement provisions due to missing details', 'Potential cost implications for healthcare systems and insurers are unknown']
The bill was introduced during the 118th Congress and referred to the House Subcommittee on Health. It did not advance beyond this stage and is now classified as failed or expired. The absence of detailed legislative text or summary suggests limited legislative momentum or prioritization within the health policy agenda during this session.
High concern review — 3 hidden impact flags detected
GovScope reviewed 3 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could increase demand for breast cancer diagnostic services, impacting healthcare providers and insurance systems.', 'Improved diagnostic access might lead to earlier detection and treatment, potentially affecting public health outcomes.', 'Healthcare infrastructure may require adjustments to accommodate changes in diagnostic service delivery.']
The absence of full bill text and official summary limits transparency and public understanding of the bill's provisions and potential impacts. The bill's failure to progress beyond subcommittee referral suggests limited legislative engagement. These factors highlight challenges in oversight and accountability for this legislative proposal.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.